Brd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelA

[1]  A. Belkina,et al.  BET domain co-regulators in obesity, inflammation and cancer , 2012, Nature Reviews Cancer.

[2]  Ming-Ming Zhou,et al.  Down-regulation of NF-κB Transcriptional Activity in HIV-associated Kidney Disease by BRD4 Inhibition* , 2012, The Journal of Biological Chemistry.

[3]  C. French.  Pathogenesis of NUT midline carcinoma. , 2012, Annual review of pathology.

[4]  Gaoxi Xiao,et al.  RUNX3 acts as a tumor suppressor in breast cancer by targeting estrogen receptor α , 2012, Oncogene.

[5]  N. Perkins,et al.  The diverse and complex roles of NF-κB subunits in cancer , 2012, Nature Reviews Cancer.

[6]  C. Chung.  Small molecule bromodomain inhibitors: extending the druggable genome. , 2012, Progress in medicinal chemistry.

[7]  S. Lowe,et al.  RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia , 2011, Nature.

[8]  Peter A. Jones,et al.  A decade of exploring the cancer epigenome — biological and translational implications , 2011, Nature Reviews Cancer.

[9]  P. Sandy,et al.  Targeting MYC dependence in cancer by inhibiting BET bromodomains , 2011, Proceedings of the National Academy of Sciences.

[10]  R. Young,et al.  BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc , 2011, Cell.

[11]  John M Denu,et al.  Disrupting the reader of histone language. , 2011, Angewandte Chemie.

[12]  B. Aggarwal,et al.  NF-κB addiction and its role in cancer: ‘one size does not fit all’ , 2011, Oncogene.

[13]  C. Rice,et al.  Suppression of inflammation by a synthetic histone mimic , 2010, Nature.

[14]  B. Aggarwal,et al.  Inhibiting NF-κB activation by small molecules as a therapeutic strategy. , 2010, Biochimica et biophysica acta.

[15]  William B. Smith,et al.  Selective inhibition of BET bromodomains , 2010, Nature.

[16]  Lin-Feng Chen,et al.  Posttranslational modifications of NF-kappaB: another layer of regulation for NF-kappaB signaling pathway. , 2010, Cellular signalling.

[17]  S. Smale,et al.  Selectivity of the NF-{kappa}B response. , 2010, Cold Spring Harbor perspectives in biology.

[18]  E. Tajkhorshid,et al.  Functional Interplay between Acetylation and Methylation of the RelA Subunit of NF-κB , 2010, Molecular and Cellular Biology.

[19]  C. Chiang,et al.  Brd4 engagement from chromatin targeting to transcriptional regulation: selective contact with acetylated histone H3 and H4 , 2009, F1000 biology reports.

[20]  Kyung-Chul Choi,et al.  Gallic Acid Suppresses Lipopolysaccharide-Induced Nuclear Factor-κB Signaling by Preventing RelA Acetylation in A549 Lung Cancer Cells , 2009, Molecular Cancer Research.

[21]  Jennifer A. Smith,et al.  Brd4 Regulation of Papillomavirus Protein E2 Stability , 2009, Journal of Virology.

[22]  N. Kelleher,et al.  Negative regulation of NF‐κB action by Set9‐mediated lysine methylation of the RelA subunit , 2009, The EMBO journal.

[23]  Hua Yu,et al.  Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors. , 2009, Cancer cell.

[24]  C. Chiang,et al.  Chromatin Adaptor Brd4 Modulates E2 Transcription Activity and Protein Stability* , 2009, Journal of Biological Chemistry.

[25]  D. Kwon,et al.  Papillomavirus E2 Proteins and the Host Brd4 Protein Associate with Transcriptionally Active Cellular Chromatin , 2009, Journal of Virology.

[26]  M. Karin,et al.  Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. , 2009 .

[27]  Michael Karin,et al.  Is NF-κB a good target for cancer therapy? Hopes and pitfalls , 2009, Nature Reviews Drug Discovery.

[28]  Ming-Ming Zhou,et al.  Brd4 Coactivates Transcriptional Activation of NF-κB via Specific Binding to Acetylated RelA , 2008, Molecular and Cellular Biology.

[29]  Danny Reinberg,et al.  Is there a code embedded in proteins that is based on post-translational modifications? , 2008, Nature Reviews Molecular Cell Biology.

[30]  I. Adcock,et al.  Epigenetic regulation of airway inflammation. , 2007, Current opinion in immunology.

[31]  Shwu‐Yuan Wu,et al.  The Double Bromodomain-containing Chromatin Adaptor Brd4 and Transcriptional Regulation* , 2007, Journal of Biological Chemistry.

[32]  Lin-Feng Chen,et al.  TGF‐β induces p65 acetylation to enhance bacteria‐induced NF‐κB activation , 2007 .

[33]  Lin-Feng Chen,et al.  TGF-beta induces p65 acetylation to enhance bacteria-induced NF-kappaB activation. , 2007, The EMBO journal.

[34]  N. Perkins.  Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway , 2006, Oncogene.

[35]  M. Karin.  Nuclear factor-κB in cancer development and progression , 2006, Nature.

[36]  M. Karin.  Nuclear factor-kappaB in cancer development and progression. , 2006, Nature.

[37]  A. Baldwin,et al.  Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. , 2006, Oncogene.

[38]  Leonard Buckbinder,et al.  NF-κB RelA Phosphorylation Regulates RelA Acetylation , 2005, Molecular and Cellular Biology.

[39]  P. Dent,et al.  Kinase 1 Activation Downregulation, and C-jun N-terminal Mediated by Oxidative Damage, Xiap Leukemia Cells through a Process B Activation Potentiates Apoptosis in Κ Nf- Inhibitor-induced Rela/p65 Acetylation and Blockade of Histone Deacetylase , 2005 .

[40]  Michael Karin,et al.  NF-kappaB: linking inflammation and immunity to cancer development and progression. , 2005, Nature reviews. Immunology.

[41]  Leonard Buckbinder,et al.  NF-kappaB RelA phosphorylation regulates RelA acetylation. , 2005, Molecular and cellular biology.

[42]  B. Aggarwal,et al.  Nuclear factor-kappaB: the enemy within. , 2004, Cancer cell.

[43]  S. Saccani,et al.  Degradation of Promoter-bound p65/RelA Is Essential for the Prompt Termination of the Nuclear Factor κB Response , 2004, The Journal of experimental medicine.

[44]  M. Mayo,et al.  Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase , 2004, The EMBO journal.

[45]  P. Howley,et al.  Interaction of the Bovine Papillomavirus E2 Protein with Brd4 Tethers the Viral DNA to Host Mitotic Chromosomes , 2004, Cell.

[46]  W. Greene,et al.  Shaping the nuclear action of NF-kappaB. , 2004, Nature reviews. Molecular cell biology.

[47]  W. Greene,et al.  Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF‐κB , 2002, The EMBO journal.

[48]  Jerard Hurwitz,et al.  A Mammalian Bromodomain Protein, Brd4, Interacts with Replication Factor C and Inhibits Progression to S Phase , 2002, Molecular and Cellular Biology.

[49]  Michael Karin,et al.  NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.

[50]  M. Karin,et al.  Missing Pieces in the NF-κB Puzzle , 2002, Cell.

[51]  Michael Karin,et al.  NF-kappaB in cancer: from innocent bystander to major culprit. , 2002, Nature reviews. Cancer.

[52]  R. Kornberg,et al.  Mammalian mediator of transcriptional regulation and its possible role as an end-point of signal transduction pathways. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[53]  M J May,et al.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.

[54]  F. Jeanmougin,et al.  The bromodomain revisited. , 1997, Trends in biochemical sciences.

[55]  E. Zandi,et al.  AP-1 function and regulation. , 1997, Current opinion in cell biology.

[56]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .

[57]  A. Baldwin,et al.  The NF-kappa B and I kappa B proteins: new discoveries and insights. , 1996, Annual review of immunology.